Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00826228 · ClinicalTrials.gov registry record · Phase 4

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

A Phase 4 study of Spinal Cord Injury and Osteoporosis, sponsored by Thomas J. Schnitzer.

Completed
Registry status
Phase 4
Development phase
12
Enrollment target
1
Study location

NCT00826228: Completed Phase 4 study of Spinal Cord Injury and Osteoporosis, sponsored by Thomas J. Schnitzer.

NCT00826228 is a Phase 4 study of Spinal Cord Injury and Osteoporosis that has completed, run by Thomas J. Schnitzer. The registered enrollment target is 12 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00826228, a Phase 4 study of Spinal Cord Injury and Osteoporosis, has completed, sponsored by Thomas J. Schnitzer.

COMPLETED
Registry status
Phase 4
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Individuals with spinal cord injury sustain significant loss of bone mass in their lower extremities (20-40% or more). This study evaluates the ability of PTH and weight-bearing, two interventions that build bone, to increase bone mass in this population.

Primary Outcome

Bone mineral density (gm/cm2) of the total hip region of interest on the left

Conditions Studied

Spinal Cord Injury Osteoporosis Bone Loss

Interventions

  • DRUG teriparatide
  • OTHER weight-bearing

Study Locations (1)

Illinois

  • Rehabilitation Institute of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2009-06
Est. Completion 2012-12
Phase Phase 4
Thomas J. Schnitzer

5 total trials

What the finished NCT00826228 record still lists

NCT00826228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (86% lower).

The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which teriparatide is the first listed.

NCT00826228 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00826228 about?

NCT00826228 is a clinical study titled "Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)". Individuals with spinal cord injury sustain significant loss of bone mass in their lower extremities (20-40% or more). This study evaluates the ability of PTH and weight-bearing, two interventions that build bone, to increase bone mass in this population.

What is the current status of trial NCT00826228?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2009-06. Estimated completion is 2012-12.

What conditions does trial NCT00826228 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Osteoporosis, Bone Loss.

What interventions are being tested in trial NCT00826228?

The interventions under investigation include: teriparatide (DRUG), weight-bearing (OTHER).

Who is sponsoring clinical trial NCT00826228?

This trial is sponsored by Thomas J. Schnitzer, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00826228 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00826228's enrollment target sits among peer trials

12 73rd of 99 higher than 21 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00826228, the US trial registry maintained by the National Library of Medicine. NCT00826228 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.